X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SUVEN LIFESCIENCES - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SUVEN LIFESCIENCES ABBOTT INDIA/
SUVEN LIFESCIENCES
 
P/E (TTM) x 41.5 18.8 221.0% View Chart
P/BV x 11.0 3.7 300.6% View Chart
Dividend Yield % 0.6 0.6 100.6%  

Financials

 ABBOTT INDIA   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
SUVEN LIFESCIENCES
Mar-18
ABBOTT INDIA/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs6,110251 2,436.2%   
Low Rs3,996155 2,578.1%   
Sales per share (Unadj.) Rs1,552.249.1 3,159.8%  
Earnings per share (Unadj.) Rs188.89.7 1,942.9%  
Cash flow per share (Unadj.) Rs196.411.4 1,724.3%  
Dividends per share (Unadj.) Rs55.001.50 3,666.7%  
Dividend yield (eoy) %1.10.7 147.2%  
Book value per share (Unadj.) Rs796.660.3 1,321.2%  
Shares outstanding (eoy) m21.25127.28 16.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.34.1 78.8%   
Avg P/E ratio x26.820.9 128.2%  
P/CF ratio (eoy) x25.717.8 144.4%  
Price / Book Value ratio x6.33.4 188.5%  
Dividend payout %29.115.4 188.7%   
Avg Mkt Cap Rs m107,37625,825 415.8%   
No. of employees `0003.31.1 309.9%   
Total wages/salary Rs m3,937613 642.5%   
Avg. sales/employee Rs Th9,929.35,832.6 170.2%   
Avg. wages/employee Rs Th1,185.1571.5 207.3%   
Avg. net profit/employee Rs Th1,207.71,153.8 104.7%   
INCOME DATA
Net Sales Rs m32,9856,253 527.5%  
Other income Rs m1,170233 502.8%   
Total revenues Rs m34,1556,485 526.7%   
Gross profit Rs m5,2451,982 264.7%  
Depreciation Rs m162213 76.0%   
Interest Rs m3846 82.5%   
Profit before tax Rs m6,2151,955 317.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,203718 306.7%   
Profit after tax Rs m4,0121,237 324.4%  
Gross profit margin %15.931.7 50.2%  
Effective tax rate %35.436.7 96.5%   
Net profit margin %12.219.8 61.5%  
BALANCE SHEET DATA
Current assets Rs m22,6555,622 402.9%   
Current liabilities Rs m6,6811,168 572.2%   
Net working cap to sales %48.471.2 68.0%  
Current ratio x3.44.8 70.4%  
Inventory Days Days6581 79.6%  
Debtors Days Days2936 81.1%  
Net fixed assets Rs m8353,325 25.1%   
Share capital Rs m213127 166.9%   
"Free" reserves Rs m16,7157,547 221.5%   
Net worth Rs m16,9287,674 220.6%   
Long term debt Rs m014 0.0%   
Total assets Rs m24,1629,135 264.5%  
Interest coverage x163.743.2 378.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.40.7 199.5%   
Return on assets %16.814.0 119.3%  
Return on equity %23.716.1 147.1%  
Return on capital %36.926.0 141.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3695,066 7.3%   
Fx outflow Rs m3,8072,001 190.2%   
Net fx Rs m-3,4383,065 -112.2%   
CASH FLOW
From Operations Rs m1,527699 218.3%  
From Investments Rs m-2,148-6 35,219.7%  
From Financial Activity Rs m-1,024-577 177.5%  
Net Cashflow Rs m-1,646116 -1,415.0%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 36.5 46.8%  
Shareholders   18,270 37,287 49.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ORCHID PHARMA LTD  CIPLA  TORRENT PHARMA  UNICHEM LAB  WYETH LTD  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 234 Points Higher; Healthcare and Realty Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets witnessed buying interest during closing hours and ended higher.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 16, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS